Valomindo 160 mg/1,5 mg tablete s prilagođenim oslobađanjem
| Name | Valomindo 160 mg/1,5 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-661290088 |
| Active Substance | valsartan indapamid |
| Composition | jedna tableta s prilagođenim oslobađanjem sadrži 160 mg valsartana i 1,5 mg indapamida |
| Pharmaceutical Form | Tableta s prilagođenim oslobađanjem |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 24.05.2024 |
| MA Period of Validity | 24.05.2029 |
| Classification Number | UP/I-530-09/22-01/310 |
| Registration Number | 381-12-01/171-24-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DA03 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
